Effect of diagnosis on variability of ICU patients in insulin sensitivity (2012)

View/ Open
Type of Content
Conference Contributions - PublishedPublisher
University of Canterbury. Mechanical EngineeringCollections
Abstract
Tight glycemic control (TGC) in intensive care unit (ICU) patients represents an active research field as it has been proved its mortality and cost reduction effects. Previous works demonstrated that insulin sensitivity plays an important role in this question. The paper investigates by two defined metrics patient's variability in insulin sensitivity based on a previously introduced (ICING) glucose-insulin model. These metrics grasp the deviations of the actual insulin sensitivity data from their predictions; hence, characterizing a patient's variability at a given time. We also introduce and examine a way to characterize variability across longer time periods and across different patients. Investigations are applied to an actual longitudinal database consisting of n = 261 patients with 47836 hours of measurement in total, with patients grouped according to diagnosis groups formed from their Apache III codes. Data was also segregated according to time spent in ICU (in days). Kruskal-Wallis-test was then employed (separately for different days) to assess whether patients in different diagnosis groups exhibit significantly different variability. Differences were further analyzed with Tukey HSD post-hoc testing. Results show that insulin sensitivity decreases with time and that differences between diagnosis groups diminish. However, there are significant differences on the first two days of stay in the ICU according to one of the metrics, with cardiac patients being more variable and gastric patients (especially non-operative ones) being less variable.
Citation
Ferenci, T., Kovacs, L., Benyo, B., Le Compte, A.J., Shaw, G.M., Chase, J.G. (2012) Effect of diagnosis on variability of ICU patients in insulin sensitivity. Budapest, Hungary: 8th IFAC Symposium on Biological and Medical Systems (BMS12), 29-31 Aug 2012. Biological and Medical Systems, 8, 1, 462-466.This citation is automatically generated and may be unreliable. Use as a guide only.
Keywords
insulin sensitivity; patient variability; statistical analysis; statistical Inference; tight glycemic controlANZSRC Fields of Research
32 - Biomedical and clinical sciences::3202 - Clinical sciences::320208 - Endocrinology32 - Biomedical and clinical sciences::3205 - Medical biochemistry and metabolomics::320502 - Medical biochemistry - carbohydrates
32 - Biomedical and clinical sciences::3202 - Clinical sciences::320212 - Intensive care
32 - Biomedical and clinical sciences::3201 - Cardiovascular medicine and haematology::320102 - Haematology
09 - Engineering::0903 - Biomedical Engineering
Related items
Showing items related by title, author, creator and subject.
-
Monte Carlo Analysis of a Subcutaneous Absorption Insulin Glargine Model: Variability in Plasma Insulin Concentrations
Razak, N.N.; Lin, J.; Wong, J.; Chase, Geoff (University of Canterbury. Mechanical Engineering, 2012)Absorption kinetics of long acting insulin such as Glargine often shows significant intra and inter-individual variability. To add this variability to the pharmacokinetics model of Glargine, ranges of variation for Glargine ... -
Improving minimal model identifiability in insulin resistant patients utilising insight from the graphical structural model identifiability method
Docherty, P.D.; Chase, Geoff (University of Canterbury. Mechanical Engineering, 2012)The Minimal Model is often used to characterize participant responses to glucose by fitting model simulations to measured data. Although the model has met significant success defining test responses of normo-glucose tolerant ... -
Virtual Patients and Clinical Trial Simulations to Improve Safety of Glucose Control in Intensive Care
Fisk, L.; Le Compte, A.J.; Shaw, Geoff; Chase, Geoff (University of Canterbury. Mechanical Engineering, 2012)Despite the potential clinical benefits of normalizing blood glucose in critically ill patients, the risk of hypoglycemia is a major barrier to widespread clinical adoption of accurate glycemic control. To compare five ...